A detailed history of Tekla Capital Management LLC transactions in Galera Therapeutics, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 898,374 shares of GRTX stock, worth $26,951. This represents 0.11% of its overall portfolio holdings.

Number of Shares
898,374
Previous 898,374 -0.0%
Holding current value
$26,951
Previous $2.3 Million 21.88%
% of portfolio
0.11%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$7.04 - $10.49 $1.01 Million - $1.51 Million
-143,471 Reduced 13.77%
898,374 $7.28 Million
Q2 2020

Aug 13, 2020

BUY
$7.14 - $14.41 $4.46 Million - $9.01 Million
625,179 Added 150.04%
1,041,845 $7.44 Million
Q4 2019

Feb 13, 2020

BUY
$9.13 - $13.9 $3.8 Million - $5.79 Million
416,666 New
416,666 $5.48 Million

Others Institutions Holding GRTX

# of Institutions
2
Shares Held
909K
Call Options Held
0
Put Options Held
0

About Galera Therapeutics, Inc.


  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $805K
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.